{
    "root": "1ddb7a71-0e47-2c7a-e063-6394a90a98b1",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Lacosamide",
    "value": "20241222",
    "ingredients": [
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "LACOSAMIDE",
            "code": "563KS2PQY5"
        }
    ],
    "indications": "lacosamide injection indicated : treatment partial-onset seizures patients 1 month age older ( 1.1 ) adjunctive therapy treatment primary generalized tonic-clonic seizures patients 4 years age older ( 1.2 )",
    "contraindications": "adults ( 17 years older ) : initial monotherapy treatment partial-onset seizures 100 mg twice daily ( 2.1 ) initial adjunctive therapy treatment partial-onset seizures primary generalized tonic-clonic seizures 50 mg twice daily ( 2.1 ) maximum recommended monotherapy adjunctive therapy 200 mg twice daily ( 2.1 ) pediatric patients 1 month less 17 years : recommended based body weight ( 2.1 ) increase based response tolerability , frequently per week ( 2.1 ) injection : intravenous oral temporarily feasible ; recommended based body weight administered two three times daily 15 60 minutes ; obtaining ecg initiation recommended certain patients ( 2.7 , 5.3 ) dose adjustment recommended severe renal impairment ( 2.4 , 12.3 ) dose adjustment recommended mild moderate hepatic impairment ; patients severe hepatic impairment recommended ( 2.5 , 12.3 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "none .",
    "indications_original": "Lacosamide injection is indicated for: Treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 )",
    "contraindications_original": "Adults (17 years and older): o Initial dosage for monotherapy for the treatment of partial-onset seizures is 100 mg twice daily ( 2.1 ) o Initial dosage for adjunctive therapy for the treatment of partial-onset seizures or primary generalized tonic-clonic seizures is 50 mg twice daily ( 2.1 ) o Maximum recommended dosage for monotherapy and adjunctive therapy is 200 mg twice daily ( 2.1 ) Pediatric Patients 1 month to less than 17 years: The recommended dosage is based on body weight ( 2.1 ) Increase dosage based on clinical response and tolerability, no more frequently than once per week ( 2.1 ) Injection: for intravenous use only when oral administration is temporarily not feasible; the recommended dosage is based on body weight and is administered two or three times daily over 15 to 60 minutes; obtaining ECG before initiation is recommended in certain patients ( 2.7 , 5.3 ) Dose adjustment is recommended for severe renal impairment ( 2.4 , 12.3 ) Dose adjustment is recommended for mild or moderate hepatic impairment; use in patients with severe hepatic impairment is not recommended ( 2.5 , 12.3 )",
    "adverseReactions_original": "None."
}